Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathway

Leukemia Research

Volumn 31, Issue 5, 2007, Pages 653-660

  Wang, Xiaojian ^a   Sun, Hongying ^b   Li, Chaolong ^b  

^a Tsinghua University   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; Granulocyte macrophage progenitor; Growth arrest; Nitric oxide

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HL 60; COLONY FORMATION; ENZYME INACTIVATION; GRANULOCYTE; HEMATOPOIESIS; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; CASPASES; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HL-60 CELLS; HUMANS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 34147140353     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.07.023     Document Type: Article

References (32)

1. Lotem J., and Sachs L. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene 21 (2002) 3284-3294
2. Alexander W.S. Cytokines in hematopoiesis. Int Rev Immunol 16 (1998) 651-682
3. Reykdal S., Abboud C., and Liesveld J. Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture. Exp Hematol 27 (1999) 441-450
4. Maciejewski J.P., Selleri C., Sato T., Cho H.J., Keefer L.K., Nathan C.F., et al. R Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 96 (1995) 1085-1092
5. Michurina T., Krasnov P., Balazs A., et al. Nitric oxide is a regulator of hematopoietic stem cell activity. Mol Ther 10 (2004) 241-248
6. Iwata N., Tamekane A., Yakushijin K., et al. Casein kinase Iepsilon down-regulates phospho-Akt via PTEN, following genotoxic stress-induced apoptosis in hematopoietic cells. Life Sci 78 (2006) 1624-1629
7. Hammerman P.S., Fox C.J., Birnbaum M.J., and Thompson C.B. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105 (2005) 4477-4483
8. Jin Z.H., Kurosu T., Yamaguchi M., Arai A., and Miura O. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene 24 (2005) 1973-1981
9. Siatskas C., Underwood J., Ramezani A., Hawley R.G., and Medin J.A. Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanisms. FASEB J 19 (2005) 1752-1754
10. Uddin S., Hussain A.R., Al-Hussein K.A., Manogaran P.S., Wickrema A., Gutierrez M.I., et al. Inhibition of phosphatidylinositol 3′-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Clin Cancer Res 11 (2005) 3102-3108
11. Bertrand F.E., Steelman L.S., Chappell W.H., et al. Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells. Leukemia 20 (2006) 1254-1260
12. Fayard E., Tintignac L.A., Baudry A., and Hemmings B.A. Protein kinase B/Akt at a glance. J Cell Sci 118 (2005) 5675-5678
13. Datta S.R., Dudek H., Tao X., et al. Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
14. Zhao S., Konopleva M., Cabreira-Hansen M., et al. Inhibition of phosphatidylinositol 3-kinase dephosphorylates Bad and promotes apoptosis in myeloid leukemias. Leukemia 18 (2004) 267-275
15. Stein G.S., Baserga R., Giordano A., et al. The molecular basis of cell cycle and growth control (1999), Wiley-Liss, New York
16. Siebert R., Willers C.P., and Opalka B. Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma. Leuk Lymphoma 23 (1996) 505-520
17. Kishimoto S., Gokoh M., Oka S., Muramatsu M., Kajiwara T., Waku K., et al. 2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. J Biol Chem 278 (2003) 24469-24475
18. Kanayasu-Toyoda T., Yamaguchi T., Uchida E., and Hayakawa T. Commitment of neutrophilic differentiation and proliferation of HL-60 cells coincides with expression of transferrin receptor. Effect of granulocyte colony stimulating factor on differentiation and proliferation. J Biol Chem 274 (1999) 25471-25480
19. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, aBcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998) 481-490
20. Kim T.H., Zhao Y., Barber M.J., Kuharsky D.K., and Yin X.M. Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. J Biol Chem 275 (2000) 39474-39481
21. Inoue A., Muranaka S., Fujita H., Kanno T., Tamai H., and Utsumi. Molecular mechanism of diclofenac-induced apoptosis of promyelocytic leukemia: dependency on reactive oxygen species, Akt, Bid, cytochrome and caspase pathway. Free Radic Biol Med 37 (2004) 1290-1299
22. Yamada K., Arita K., Kobuchi H., et al. Cholesteryl-hemisuccinate-induced apoptosis of promyelocytic leukemia HL-60 cells through a cyclosporin A-insensitive mechanism. Biochem Pharmacol 65 (2003) 339-348
23. 2+ and caspase-3 in capsaicin-induced apoptosis of human leukemia HL-60 cells. Anticancer Res 26 (2006) 1965-1971
24. Hong L., Piao Y., Han Y., Wang J., Zhang X., Du Y., et al. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther 4 (2005) 1936-1942
25. Hsu M.H., Kuo S.C., Chen C.J., Chung J.G., Lai Y.Y., and Huang L.J. 1-(3,4-Dimethoxyphenyl)-3,5-dodecenedione (I6) induces G1 arrest and apoptosis in human promyelocytic leukemia HL-60 cells. Leuk Res 29 (2005) 1399-1406
26. Seo Y.J., Jeon M.H., Lee J.H., et al. Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27. Exp Mol Med 37 (2005) 624-630
27. cip1/waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82 (1995) 675-684
28. kip1. Nature 404 (2000) 782-787
29. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death. Mach Cell 91 (1997) 231-241
30. Del Peso L., Gonzalez-Garcia M., Page C., Herrera R., and Nunez G. Interleukin-3-induced phosphorylation of Bad through the protein kinase Akt. Science 278 (1997) 687-689
31. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111 (2002) 331-342
32. Majewski N., Nogueira V., Robey R.B., and Hay N. Akt inhibits apoptosis downstream of Bid cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol 24 (2004) 730-740